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Abstract
The present cross-sectional, population-based study was designed to
evaluate the performance of the FEV1/FEV6 ratio  for the detection of
airway-obstructed subjects compared to the FEV1/FVC <0.70 fixed
ratio test, as well as the lower limit of normality (LLN) for 1000
subjects ≥40 years of age in the metropolitan area of São Paulo, SP,
Brazil. After the exclusion of 37 (3.7%) spirometries, a total of 963
pre-bronchodilator (BD) and 918 post-BD curves were constructed.
The majority of the post-BD curves (93.1%) were of very good quality
and achieved grade A (762 curves) or B (93 curves). The FEV1/FEV6
and FEV1/FVC ratios were highly correlated (r2 = 0.92, P < 0.000).
Two receiver operator characteristic curves were constructed in order
to express the imbalance between the sensitivity and specificity of the
FEV1/FEV6 ratio compared to two FEV1/FVC cut-off points for
airway obstruction: equal to 70 (area under the curve = 0.98, P <
0.0001) and the LLN (area under the curve = 0.97, P < 0.0001), in the
post-BD curves. According to an FEV1/FVC <0.70, the cut-off point
for the FEV1/FEV6 ratio with the highest sum for sensitivity and
specificity was 0.75. The FEV1/FEV6 ratio can be considered to be a
good alternative to the FEV1/FVC ratio for the diagnosis of airway
obstruction, both using a fixed cut-off point or below the LLN as
reference. The FEV1/FEV6 ratio has the additional advantage of being
an easier maneuver for the subjects and for the lung function techni-
cians, providing a higher reproducibility than traditional spirometry
maneuvers.
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Introduction
The definition of airflow limitation by
spirometry classically considers either a
FEV1/FVC ratio <0.70 or a value below the
lower limit of normality (LLN) derived from
reference equations (1-3). Some studies have
recently suggested that reducing the forced
expiratory maneuver to a 6-s duration (also
called FEV6) could replace the forced vital
capacity (FVC) maneuver as a surrogate of
the FEV1/FVC ratio for the diagnosis of
airway obstruction (4-8). The advantages of
FEV6 described in the literature are: easy
execution (for patients and technicians)
(9,10), elimination of very low flow sensor
accuracy limitations at the end of FVC ma-
neuvers, reduction in the total duration of
the spirometry test, and possibly a reduction
in spirometry complications (such as syn-
cope) (11-13).
Analysis of published studies shows that
the criteria adopted to define obstruction
from the FEV1/FEV6 ratio are quite variable:
some studies used the sensitivity and speci-
ficity values associated with receiver opera-
tor characteristic (ROC) curve analysis to
find the best cut-off point (3,6), some used
an empiric fixed FEV1/FEV6 ratio of 0.70
(4), and finally others used the LLN, derived
from reference equations, as the best option
(5,7,11,12,14). Important limitations of such
studies are: the reference equations used
were developed in a setting different from
that of the subjects in whom the FEV1/FEV6
ratio was measured and there was a wide
variation in the population concerning age,
height, weight, and ethnicity, possibly lead-
ing to a limitation of the external validation
(8). Finally, there was the possibility of a
selection bias since some studies were con-
ducted on patients referred to pulmonary
function test laboratories, a fact that might
influence the accuracy of the FEV1/FEV6
ratio (4,5,9,11,14).
The PLATINO study was conducted in
order to determine the prevalence of chronic
obstructive pulmonary disease (COPD) in
the population of five large cities in Latin
America (15). Spirometric reference equa-
tions derived from the PLATINO study (in-
cluding FEV6 and FEV1/FEV6) have been
published (3). Specific data regarding the
Brazilian subsample are available (16).
The present study was designed to evalu-
ate the performance of the FEV1/FEV6 ratio
in detecting airflow limitation using the
FEV1/FVC <0.70 fixed ratio and LLN in the
Brazilian subsample of the PLATINO study.
Material and Methods
Participants
Between December 2002 and March
2003, subjects aged 40 years and over (COPD
target population) were recruited according
to a multi-stage cluster sampling strategy, in
order to obtain representative samples of
adults living in the metropolitan area of São
Paulo, the largest city in South America (690
m above sea level and 23º latitude South),
which has a population of 17.3 million
people. Within the 1113 households sam-
pled there were 1150 individuals eligible for
the study; of these, 1000 answered the ques-
tionnaires, and 963 performed spirometry
(with 918 completing the post-bronchodila-
tor (BD) phase). The overall non-response
rate was 15.3%, taking into account both
household and individual contact failures
and refusals (including refusals only for spi-
rometry). Therefore, spirometry analyses
were carried out using the post-BD curves.
Instruments and examinations
The PLATINO core questionnaire is
a composite including sections of the
following questionnaires: ATS/DLD (17), Eu-
ropean Community Respiratory Health Sur-
vey II (18) and Lung Health Study
(19). It contains questions about respiratory
symptoms, COPD risk factors, previous medi-
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cal diagnosis and diagnostic tests, and medi-
cations. The exclusion criteria for the study
were mental disease and institutionalization.
Anthropometric measurements
Height and weight were measured with a
portable Seca® stadiometer (Hamburg, Ger-
many) with 0.1-cm precision and an elec-
tronic Tanita® scale (Tokyo, Japan) with
200-g precision, respectively. Body mass
index was calculated by dividing weight by
squared height (kg/m2).
Spirometry
Spirometry was carried out by personnel
who had received training in a quality con-
trol course for spirometry testing approved
by the National Institute for Occupational
Safety and Health. Two spirometric read-
ings were taken, one at baseline, and the
other 15 min after the application of 200 µg
salbutamol through a spacer, and their re-
producibility was graded according to qual-
ity control grades A to F. Subjects were
seated and used nose clips. An ultrasound
spirometer (Easy One, NDD Technopark,
Zurich, Switzerland), which met all ATS
quality control criteria was used (20). Cali-
bration was verified daily with a 3-L sy-
ringe. All spirometry results were sent to the
investigators in the Quality Control center,
located in Mexico City, Mexico, and a weekly
feedback report to the center in São Paulo,
Brazil, was provided (21). The spirometry
reference equations used in the present study
were developed from the data for five Latin
American cities in the PLATINO study, in-
cluding São Paulo (3). FEV6 was obtained
from the same FVC curve. Exclusion criteria
for spirometry were: thoracic or abdominal
surgery, myocardial infarction, eye surgery
(or detached retina), and hospitalization for
any cardiac problem in the previous three
months, as well as current treatment for tu-
berculosis or pregnancy.
Statistical analysis
Data are reported as means ± SD. The
Student t-test and ANOVA were used to
compare means. The performance of the
separate sets of variables was analyzed us-
ing two-by-two tables. Sensitivity, specific-
ity, positive predictive value, negative pre-
dictive value, and ROC curves were calcu-
lated and compared using a fixed cut-off
point of FEV1/FVC <0.70 or based on the
identification of the LLN (derived from the
PLATINO spirometry reference equations)
as reference for airway obstruction (3). The
level of significance was set at P < 0.05.
Analyses were carried out using the STATA
and SPSS (v13) programs.
Ethics
The Ethics Committee of the Federal
University of São Paulo approved the study
and written informed consent was obtained
from each subject. For additional data, we
suggest consultation of PLATINO methods
(22).
Results
Sample baseline characteristics
One thousand subjects aged 40 years or
more were interviewed in the great metro-
politan area of São Paulo, Brazil. Thirty-
seven (3.7%) subjects did not meet the inclu-
sion criteria for spirometry, 963 subjects
performed pre-BD spirometry and 918 com-
pleted the post-BD phase. The baseline char-
acteristics of the sample studied are shown
in Table 1.
Twenty-four percent of the subjects (240)
were current smokers and 9.1% (91 patients)
were former smokers.
Spirometry quality control
Quality control of the flow-volume curves
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Table 3. Sensitivity and specificity of the FEV1/FEV6 ratio compared to FEV1/FVC = 0.70, post-BD curves.
Post-BD FEV1/FVC = 70
Sensitivity Specificity PPV NPV Prevalence
FEV1/FEV6 = 70 44.4% (36.2-52.9) 100% (99.4-100) 100% (92.9-100) 90.6% (88.4-92.5) 7.0% (5.4-8.9)
FEV1/FEV6 = 71 54.9% (46.4-63.1) 100% (99.4-100) 100% (94.2-100) 92.3% (90.1-94.0) 8.6% (6.9-10.6)
FEV1/FEV6 = 72 60.4% (51.9-68.4) 99.6% (98.8-99.9) 96.7% (89.9-99.1) 93.11% (91.1-94.7) 9.8% (8.0-12.0)
FEV1/FEV6 = 73 72.2% (64.0-79.2) 99.5% (98.6-99.8) 96.3% (90.2-98.8) 95.1% (93.3-96.4) 11.8% (9.8-14.1)
FEV1/FEV6 = 74 79.2% (71.4-85.3) 99.0% (97.9-99.5) 93.44% (87.1-96.9) 96.2% (94.6-97.4) 13.3% (11.2-15.7)
FEV1/FEV6 = 75 88.2% (81.5-92.8) 97.4% (96.0-98.4) 86.4% (79.5-91.3) 97.8% (96.4-98.7) 16.0% (13.7-18.6)
FEV1/FEV6 = 76 90.3% (83.9-94.4) 93.7% (91.2-94.9) 73.44% (66.2-79.7) 98.1% (96.8-98.9) 19.3% (16.8-22.0)
FEV1/FEV6 = 77 93.1% (87.3-96.4) 90.6% (88.2-92.5) 64.7% (57.8-71.1) 98.6% (97.3-99.3) 22.54% (19.9-25.4)
FEV1/FEV6 = 78 94.4% (89.0-97.4) 86.2% (83.3-88.5) 56.0% (49.5-62.3) 98.8% (97.6-99.4) 26.4% (23.6-29.4)
FEV1/FEV6 = 79 97.2% (92.1-99.1) 80.87% (86.2-90.8) 48.6% (42.7-54.5) 98.4% (98.3-99.8) 31.4% (28.4-34.5)
Data are reported as percent with 95% confidence intervals in parentheses. PPV = positive predictive value; NPV = negative predictive value. For
other abbreviations, see legend to Table 1.
Table 1. Characteristics of the study group.
Variables Mean ± SD
Age (years) 55.2 ± 11.3
Weight (kg) 70 ± 15.7
Height (cm) 160.1 ± 9.5
BMI (kg/m2) 27.3 ± 5.6
Tobacco exposure (pack-years) 18.3 ± 22.7
FVC (L) pre-BD 3.4 ± 1
FEV1 (L) pre-BD 2.6 ± 0.8
FEV1/FVC (%) pre-BD 75.6 ± 9.4
FEV6 (L) pre-BD 3.3 ± 1
FEV1/FEV6 (%) pre-BD 78.7 ± 7.6
FVC (L) post-BD 3.4 ± 0.95
FEV1 (L) post-BD 2.7 ± 0.8
FEV1/FVC (%) post-BD 77 ± 9.2
FEV6 (L) post-BD 3.3 ± 0.9
FEV1/FEV6 (%) post-BD 80.7 ± 7.3
Intratest coefficient of variability of post-BD FEV6 2.23 ± 7.3
Intratest coefficient of variability of post-BD FVC 1.86 ± 2.25
Intratest coefficient of variability of post-BD FEV1/FEV6 0.74 ± 0.92
Intratest coefficient of variability of post-BD FEV1/FVC 1.23 ± 1.51
Data are reported as means ± SD for 1000 subjects (434 males and 566
females). BMI = body mass index; FVC = forced vital capacity; FEV = forced
expiratory volume; BD = bronchodilator.
Table 2. Sensitivity and specificity of the FEV1/FEV6 ratio compared to FEV1/FVC = 70, pre-BD curves.
Pre-BD FEV1/FVC = 70
Sensitivity Specificity PPV NPV Prevalence
FEV1/FEV6 = 70 47.9% (41.2-54.8) 100% (99.4-100) 100% (95.6-100) 86.7% (84.3-88.9) 10.9% (9.0-13.1)
FEV1/FEV6 = 71 56.6% (49.8-63.2) 99.7% (98.9-100) 98.4% (93.8-99.7) 88.6% (86.2-90.7) 13.1% (11.0-15.3)
FEV1/FEV6 = 72 63.9% (57.1-70.2) 99.4% (98.5-99.8) 97.2% (92.6-99.1) 90.4% (88.1-92.2) 15.0% (12.8-17.4)
FEV1/FEV6 = 73 73.0% (66.6-78.7) 99.1% (97.9-99.5) 95.8% (91.2-98.1) 92.9% (90.8-94.5) 17.3% (15.0-19.9)
FEV1/FEV6 = 74 83.1% (77.3-87.7) 98.1% (96.8-98.9) 92.9% (88.1-95.9) 95.2% (93.3-96.5) 20.4% (17.9-23.1)
FEV1/FEV6 = 75 89.0% (84.0-92.7) 95.4% (93.6-96.8) 85.2% (79.7-89.4) 96.7% (95.1-97.8) 23.8% (21.2-26.6)
FEV1/FEV6 = 76 94.06% (89.8-96.7) 91.0% (88.6-92.9) 75.5% (69.8-80.3) 98.1% (96.7-98.9) 28.3% (25.5-31.3)
FEV1/FEV6 = 77 95.89% (92.1-98.0) 85.7% (83.0-88.1) 66.5% (60.9-71.6) 98.6% (97.3-99.3) 32.8% (29.9-35.9)
FEV1/FEV6 = 78 97.7% (94.4-99.2) 80.0% (76.9-82.8) 59.0% (53.7-64.0) 98.8% (97.5-99.5) 37.7% (34.6-40.8)
FEV1/FEV6 = 79 98.6% (95.7-99.6) 72.3% (69.3-75.9) 51.7% (46.8-56.5) 99.4% (98.2-99.8) 43.5% (40.4-46.7)
Data are reported as percent with 95% confidence intervals in parentheses. PPV = positive predictive value; NPV = negative predictive value. For
other abbreviations, see legend to Table 1.
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was evaluated by analyzing the reproducibil-
ity of the three best curves for each subject, in
both phases of spirometry (pre- and post-BD).
The majority of the post-BD curves (93.1%)
was of very good quality, achieving grade A
(762 curves) or B (93 curves). Twenty-eight
curves achieved grade C (3.05%) and 35 (3.8%)
achieved D, E, or F grades.
Analysis of the sensitivity and specificity of
the FEV1/FEV6 ratio
Before the analysis of accuracy, a scat-
terplot graph between post-BD FEV1/FEV6
and FEV1/FVC ratios was constructed, and
r2 = 0.92 (P < 0.000) was found.
A FEV1/FVC ratio of 0.70 was taken as
the reference value for the diagnosis of air-
way obstruction. The sensitivity and speci-
ficity of the FEV1/FEV6 ratio were analyzed
for both the pre-BD and post-BD curves
(Tables 2 and 3, respectively). The highest
sum of sensitivity and specificity was de-
tected with an FEV1/FEV6 ratio threshold of
0.75 post-BD. Two ROC curves were con-
structed in order to express the balance be-
tween the sensitivity and specificity of the
FEV1/FEV6 ratio compared to two FEV1/
FVC cut-off points for airway obstruction:
one considered values equal to 0.70 and the
other values below the LLN. The results are
shown in Figure 1.
COPD diagnosis and misclassification
according to the post-BD FEV1/FEV6 ratio
The diagnosis of air flow limitation
according to a fixed post-BD FEV1/FVC
ratio <0.70 (as stated by the ATS/ERS and
Brazilian guidelines) was compared to the
diagnosis of air flow based on a post-BD
FEV1/FEV6 ratio <0.75, using a 2 x 2 table
(Table 4). Based on an FEV1/FVC ratio
<0.70, 15.7% of the sample was considered
to have airway obstruction, while this num-
ber slightly increased to 16.03% taking into
consideration an FEV1/FEV6 ratio <75%.
Figure 1. Area under the receiver operator characteristic curves (AUC) and 95% confidence
intervals for the FEV1/FEV6 ratio compared to an FEV1/FVC ratio equal to the lower limit of
normality (LLN) and to 0.70. FEV = forced expiratory volume; FVC = forced vital capacity.
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The positive and negative predictive values
were 85.8 and 97.8%, respectively. Discor-
dant diagnosis was found in 4.14% of cases
(Table 4).
A cut-off point using the LLN derived
from PLATINO reference equations was also
analyzed (Table 5). A discordant diagnosis
Table 4. Analysis of discordant cases when using
the FEV1/FEV6 <75 and FEV1/FVC <70 ratios for
airway obstruction with post-BD curves.
FEV1/FEV6 FEV1/FVC Total
<70% ≥70%
<75% 127 21 148
≥75% 17 753 770
Total 144 773 918
For abbreviations, see legend to Table 1.
Table 5. Analysis of the discordant cases when
using the FEV1/FEV6 and FEV1/FVC ratio <LLN
for airway obstruction with post-BD curves.
FEV1/FEV6 FEV1/FVC post-BD Total
<LLN ≥LLN
<LLN 117 17 134
≥LLN 23 806 829
Total 140 823 963
LLN = lower limit of normality. For other abbrevia-
tions, see legend to Table 1.
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was present in 40 (4.35%) of the subjects
studied.
Discussion
The present study showed that the FEV1/
FEV6 ratio is a good substitute for the detec-
tion of airway-obstructed subjects using ei-
ther an FEV1/FVC ratio <0.70 (fixed ratio)
or a threshold below the LLN as reference.
The main strengths of the present study are
the fact that the study group consisted of a
randomized population-based sample (15,16)
and the use of a set of spirometry reference
equations derived from the same sample (3).
The best cut-off point of the FEV1/FEV6
ratio was 0.75. These aspects were consid-
ered to be points to be addressed in future
studies (9). Two other studies showed a simi-
lar cut-off point (0.73) of the FEV1/FEV6
ratio for the detection of airway obstruction,
both using the fixed FEV1/FVC <0.70 ratio
for comparison. Vandevoorde et al. (9) used
a spirometry database of referenced patients
from a medical facility, whereas Melbye et
al. (10) recruited subjects from a highly
homogeneous population-based sample in a
northern city of Norway. Despite the differ-
ent population background between these
two studies and the present one, a similar
cut-off point for the FEV1/FEV6 ratio was
found. The advantage of using a fixed cut-
off value for the FEV1/FEV6 ratio instead of
choosing the LLN from a reference equation
to diagnose airway obstruction is empha-
sized by the main COPD guidelines (1,13).
The specific use of the FEV1/FEV6 ratio for
the diagnosis of airflow obstruction has the
advantage of being less time consuming and
easier for the patient and technician. This
should be an interesting point to consider
when establishing diagnostic units for respi-
ratory diseases in large primary care centers.
Analysis of the ROC curves for the FEV1/
FVC ratio using the value below 0.70 and
lower values than the LLN as cut-off points
to predict the best accuracy showed similar
results in identifying a cut-off for the FEV1/
FEV6 ratio according to the analysis of the
95%CI (Tables 2, 3, 4, and 5, Figure 1).
Besides the fact that the two parameters had
an excellent correlation, the best cut-off point
to be chosen in clinical practice should take
into account the proportion of wrong diag-
noses (discordant cases), which in the pres-
ent study could be considered small, i.e.,
about 4% (Tables 4 and 5).
The authors believe that this new infor-
mation will set a new basis for the clinical
judgment of which parameter and cut-off
point should be chosen as a reference for
clinical use.
Study limitations
The present study was originally designed
to estimate COPD prevalence in a popula-
tion-based survey. The reference values used
in this study were based on those obtained
for the residents of five Latin American
cities of the PLATINO study (15) as a whole.
Considered separately, no city subsample
had enough power to develop local equa-
tions.
We may conclude that the FEV1/FEV6
ratio can be considered a good alternative to
the FEV1/FVC ratio in the diagnosis of air-
way obstruction, either considering a fixed
cut-off point or a value below the LLN.
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